NASDAQ: IOSPInnospec Inc Stock Ownership - Who owns Innospec?
Insider buying vs selling
Have Innospec Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David B. Jones | SVP GC CCO | 2026-03-03 | 1,028 | $75.64 | $77.76kSell |
| Corbin Barnes | SVP Corporate Dev and IR | 2026-02-27 | 166 | $78.34 | $13.00kSell |
| Patrick Williams | PRESIDENT CEO | 2026-02-27 | 7,966 | $78.34 | $624.06kSell |
| Larry Padfield | Director | 2026-02-27 | 287 | $76.30 | $21.90kSell |
| Larry Padfield | Director | 2026-02-27 | 307 | $76.79 | $23.57kSell |
| Claudia Poccia | Director | 2026-02-27 | 119 | $76.56 | $9.11kSell |
| Claudia Poccia | Director | 2026-02-27 | 119 | $76.56 | $9.11kSell |
| Claudia Poccia | Director | 2026-02-27 | 57 | $76.30 | $4.35kSell |
| Claudia Poccia | Director | 2026-02-27 | 62 | $76.79 | $4.76kSell |
| Milton C. Blackmore | Director | 2026-02-27 | 594 | $76.56 | $45.47kSell |
IOSP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IOSP insiders and whales buy or sell their stock.
IOSP Shareholders
What type of owners hold Innospec Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jeffrey L. Et Al Gendell | 28.47% | 7,013,451 | $580.92M | Insider |
| Blackrock Inc | 15.75% | 3,878,975 | $321.30M | Institution |
| Allspring Global Investments Holdings LLC | 9.40% | 2,315,942 | $191.83M | Institution |
| Tontine Capital Partners L P | 8.57% | 2,111,800 | $174.92M | Insider |
| Vanguard Portfolio Management LLC | 7.55% | 1,860,091 | $154.07M | Institution |
| Dimensional Fund Advisors LP | 5.04% | 1,242,089 | $102.88M | Institution |
| Vanguard Capital Management LLC | 4.53% | 1,114,598 | $92.32M | Institution |
| State Street Corp | 3.92% | 964,335 | $79.88M | Institution |
| Victory Capital Management Inc | 3.51% | 864,994 | $71.65M | Institution |
| Nuveen LLC | 2.61% | 643,248 | $53.28M | Institution |
IOSP vs Specialty Chemical Stocks
Innospec Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.